SCHEMBL15968199

SCHEMBL15968199

O=C(C=Cc1ccccc1)C(=Cc1ccccc1)C(Cl)Cl.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.58
CYP2C9 P11712 3/20 0.58
PLIN1 O60240 2/20 0.58
LMNA P02545 2/20 0.58
MAPT P10636 2/20 0.58
RECQL P46063 2/20 0.58
PLIN5 Q00G26 2/20 0.58
ABHD5 Q8WTS1 2/20 0.58
CYP2D6 P10635 2/20 0.58
F3 P13726 2/20 0.58
ALDH1A1 P00352 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
HDAC3 O15379 2/20 0.44
HDAC4 P56524 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
TNKS O95271 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloroform SCHEMBL1367016 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT
Chloroform SCHEMBL7629150 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT
Chloroform SCHEMBL28370740 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT
Chloroform SCHEMBL2128854 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT
Chloroform SCHEMBL2128849 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT
Chloroform SCHEMBL2832028 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT
Chloroform SCHEMBL18788602 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT
Chloroform SCHEMBL84057 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT
Chloroform SCHEMBL29371090 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT
Chloroform SCHEMBL1827856 0.82 CYP1A2 (0.79) CYP1A2CYP2C9PLIN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2763976-B1 2-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS MERCK SHARP & DOHME (US) 2016-05-18 EP disclosed
US-9216173-B2 2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors MERCK SHARP & DOHME CORP. (US) 2015-12-22 US disclosed
US-20140243336-A1 2-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors MERCK SHARP & DOHME LLC 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243336-A1 2-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors SYK, BTK, LCK CYP1A2 1640/4885CYP2C9 1514/4885PLIN1 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.